12.6 C
New York
Friday, April 26, 2024

Moderna’s Personalized mRNA Cancer Vaccine Shows Promising Results in Early Trial

Moderna’s personalized cancer vaccine was shown to reduce the risk of recurrence in patients with stage 3 or 4 melanoma in a phase 2b clinical trial. …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,317FansLike
396,312FollowersFollow
2,290SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x